Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Heart (British Cardiac Society)
|
December 9, 2010
β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure
Giuseppe Ambrosio, Marcus D Flather, Michael Böhm, et al.
JAMA
|
May 3, 2007
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006
Keith A A Fox, Philippe Gabriel Steg, Kim A Eagle, et al.
Trials
|
February 27, 2008
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)
David C Crossman, Allison C Morton, Julian P Gunn, et al.
The American Journal of Cardiology
|
August 6, 2002
Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)
Philippe Gabriel Steg, Robert J Goldberg, Joel M Gore, et al.
Geriatrics (Basel, Switzerland)
|
April 24, 2019
Determinants of Length of Stay Following Total Anterior Circulatory Stroke
James P Curtain, Man Yu, Allan B Clark, et al.
American Heart Journal
|
December 9, 2003
Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Andrzej Budaj, David Brieger, Ph Gabriel Steg, et al.
European Journal of Heart Failure
|
April 2, 2011
Predictors of clinical outcomes in elderly patients with heart failure
Luis Manzano, Daphne Babalis, Michael Roughton, et al.
Circulation
|
April 20, 2011
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial
Stephen D Wiviott, Marcus D Flather, Michelle L O'Donoghue, et al.
European Journal of Heart Failure
|
July 6, 2012
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS
Bart A Mulder, Dirk J van Veldhuisen, Harry J G M Crijns, et al.
European Heart Journal
|
August 1, 2014
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
Allison C Morton, Alexander M K Rothman, John P Greenwood, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Heart (British Cardiac Society)
|
December 9, 2010
β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure
Giuseppe Ambrosio, Marcus D Flather, Michael Böhm, et al.
JAMA
|
May 3, 2007
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006
Keith A A Fox, Philippe Gabriel Steg, Kim A Eagle, et al.
Trials
|
February 27, 2008
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)
David C Crossman, Allison C Morton, Julian P Gunn, et al.
The American Journal of Cardiology
|
August 6, 2002
Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)
Philippe Gabriel Steg, Robert J Goldberg, Joel M Gore, et al.
Geriatrics (Basel, Switzerland)
|
April 24, 2019
Determinants of Length of Stay Following Total Anterior Circulatory Stroke
James P Curtain, Man Yu, Allan B Clark, et al.
American Heart Journal
|
December 9, 2003
Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Andrzej Budaj, David Brieger, Ph Gabriel Steg, et al.
European Journal of Heart Failure
|
April 2, 2011
Predictors of clinical outcomes in elderly patients with heart failure
Luis Manzano, Daphne Babalis, Michael Roughton, et al.
Circulation
|
April 20, 2011
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial
Stephen D Wiviott, Marcus D Flather, Michelle L O'Donoghue, et al.
European Journal of Heart Failure
|
July 6, 2012
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS
Bart A Mulder, Dirk J van Veldhuisen, Harry J G M Crijns, et al.
European Heart Journal
|
August 1, 2014
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
Allison C Morton, Alexander M K Rothman, John P Greenwood, et al.
Page
of 8